AbbVie has signed a definitive agreement to acquire Cerevel Therapeutics and its neuroscience pipeline – including antipsychotic emraclidine – for approximately $8.7 billion.
Cerevel s pipeline.
The European Commission has granted a label expansion of the combination treatment KAFTRIO® with ivacaftor, for children aged two to five years old with cystic fibrosis. The treatment from .
The European Medicines Agency has validated the Marketing Authorisation Application for imetelstat, a first-in-class telomerase inhibitor as a treatment for transfusion-dependent anaemia in lower.
BioNTech SE and the UK government have jointly agreed to provide up to 10,000 patients with personalised cancer immunotherapies by 2030.
Signing of this agreement builds on a memorandum of.